![](https://safeminds.org/wp-content/uploads/Mom-doing-research_395927770_wp-185x97.jpg)
Community Shares | December 18th 2023
A recent study has examined whether exposure to a mixture of six phthalate metabolites during pregnancy is associated with autism spectrum disorder (ASD)-related behaviors in children. The authors used data from two prospective pregnancy and birth cohorts – the Health Outcomes and Measures of the Environment (HOME) and the Early Autism Risk Longitudinal Investigation (EARLI) […]
![](https://safeminds.org/wp-content/uploads/flame-retardant_wp-185x97.jpg)
Exposure to PBDEs Affects Immune Cell Functioning in Children with Autism
Research Highlights the Associations Between Immune Response of Environmental Toxicants and Neurodevelopment A recent MIND Institute study has found that exposure to the environmental toxicant polybrominated diphenyl ether (PBDE ) affects immune cell function differently in children with autism compared to neurotypical children. PBDEs are a class of chemicals added to certain manufactured products to […]
![](https://safeminds.org/wp-content/uploads/Pregnant-mom-sick_wp-185x97.jpg)
Study Ties Maternal Autoimmune Disease with the Risk of ASD in Offspring
Findings Show that Children Whose Mothers Have Sjogren’s Syndrome or Rheumatoid Arthritis Have a Higher Cumulative Risk of Autism Researchers from Taiwan recently investigated the association between prenatal exposure to maternal autoimmune disease and the risk of autism spectrum disorders (ASD) in offspring. The study used data from Taiwan’s National Health Insurance Database and Taiwan’s […]
![](https://safeminds.org/wp-content/uploads/mom-on-laptop_wp-185x97.gif)
Community Shares | December 11th 2023
A Belgian research team has recently studied how intranasal administration of oxytocin affects amygdala functional connectivity and cardiac autonomic arousal in children with autism. The researchers conducted a double-blind, randomized pharmaco-neuroimaging trial of 57 children with autism aged 8 to 12 years. The results revealed that oxytocin reduced intrinsic amygdala-orbitofrontal connectivity, especially after the 4-week […]
![](https://safeminds.org/wp-content/uploads/molecular-protein_208547728_1600-185x97.jpg)
Pancreatic Replacement Therapy Improves Maladaptive Behaviors in Preschoolers with ASD
Study Suggests that Researchers Critical of Earlier Types of Enzyme Therapy Were Incorrect New research published in JAMA Network has evaluated the use of high-protease pancreatic therapy in 190 preschool children with autism spectrum disorder (ASD) to determine if it improved maladaptive behaviors such as irritability or agitation. High-protease pancreatic treatment was analyzed using the […]
![](https://safeminds.org/wp-content/uploads/pills_239680334_1600-1-185x97.jpg)
Antipsychotic Medications Above 100 mg Linked to Increased Risk of Death in Young Adults
However, No Association Found for Antipsychotic Treatment Under 100 mg for Children Aged 5 to 17 A new original investigation by researchers at Vanderbilt University School of Medicine set out to compare the mortality rates for patients aged 5 to 24 years who began treatment with antipsychotic medications versus control psychiatric medications (e.g., α agonists, […]